BFM
CNMD icon

Boothbay Fund Management’s CONMED CNMD Stock Holding History

Boothbay Fund Management’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$798K Buy
22,573
+8,391
+59% +$341K 0.01% 1071
2025
Q4 		$576K Buy
14,182
+6,796
+92% +$296K 0.01% 1056
2025
Q3 		$347K Buy
+7,386
New +$383K 0.01% 1366
2024
Q2 		– Sell
-93,014
Closed -$7.45M – 1569
2024
Q1 		$7.45M Buy
+93,014
New +$8.29M 0.14% 120
2023
Q1 		– Sell
-37,998
Closed -$3.37M – 2178
2022
Q4 		$3.37M Buy
37,998
+20,911
+122% +$1.74M 0.08% 372
2022
Q3 		$1.37M Buy
+17,087
New +$1.61M 0.03% 737

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

Boothbay Fund Management's CNMD Position: Q1 2026 in Review

Boothbay Fund Management increased its CONMED (CNMD) stake by 59% in Q1 2026, buying an estimated $341K and bringing the position to 22,573 shares worth $798K. The position accounts for 0.01% of the portfolio, ranked #1071.

Boothbay Fund Management first reported a position in CNMD in Q3 2022 and has held it in 6 quarters since. The position peaked at $7.45M in Q1 2024. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

  • Boothbay Fund Management held 22,573 shares of CONMED worth $798K as of Q1 2026.
  • Boothbay Fund Management bought 8,391 CONMED shares in Q1 2026, an estimated $341K.
  • CONMED made up 0.01% of Boothbay Fund Management's portfolio in Q1 2026, its #1071 holding.
  • Boothbay Fund Management first reported a position in CONMED in Q3 2022 and has held it in 6 quarters since.
  • Boothbay Fund Management's CONMED position peaked at $7.45M in Q1 2024.
  • 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.